Deposit Contracts to Increase Accessibility of a Contingency Management Intervention to Reduce Problematic Drinking

Sponsor
University of North Texas, Denton, TX (Other)
Overall Status
Recruiting
CT.gov ID
NCT05837611
Collaborator
The University of Texas Health Science Center at San Antonio (Other)
80
1
2
24.7
3.2

Study Details

Study Description

Brief Summary

This study will examine the effects of an incentive-based intervention (for reducing alcohol use) that would be sustainable, easily accessible intervention using remote alcohol monitoring and deposit contracts, targeting individuals who would not be reached by more traditional forms of treatment due to barriers such as time constraints, attitudes, and stigma.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Deposit Contract
  • Other: Transdermal Alcohol Monitoring
N/A

Detailed Description

Deposit contracts are effective at treating a wide variety of problems: smoking cessation, weight loss, and increasing physical activity. Despite the promise of deposit contracts, few earlier studies targeted problem drinking, since doing so required burdensome frequent monitoring - now overcome by remote alcohol monitoring. Earlier work relied on self- and collateral reports, breath alcohol concentrations during clinic visits, or an indirect non-specific marker of alcohol use. Despite these difficulties, earlier studies of deposit contracts were encouraging, with notable increases in: therapy participation; retention ; and abstinence duration compared to previous reports. Collectively, these studies show the potential of deposit contracts to reduce problem drinking but provide only limited evidence of its effectiveness. Still, these studies, and our recent success using contingency management with remote alcohol monitoring, provide a compelling rationale for examining whether a deposit contract program might provide a feasible, effective, and accessible way of helping people reduce drinking. Though there is limited systematic research on deposit contracts, deposit contract programs for various problems are widely available and have proven quite attractive. For example, a deposit contract weight loss website, has over 887,000 users with $62M in incentives paid. However, it is unclear if deposit contracts would be acceptable (and therefore feasible) to individuals interested in reducing their problem drinking. Therefore, we feel that the proposed deposit contract intervention utilizing remote alcohol monitoring could be a widely available and acceptable intervention for problem drinking for three reasons: (1) because of the effectiveness and convenience of our contingency management intervention using remote alcohol monitoring; (2) because of the widespread success of other deposit contract programs like DietBetã; and (3) because the potentially increased attractiveness and effectiveness of an intervention that can return an amount greater than the deposit. The adoption of a deposit contract intervention plus remote alcohol monitoring will only be accelerated by the "FitBit"-style alcohol monitoring devices being developed by many companies (we are currently independently evaluating one such device). However, making deposit contracts widely available will need evidence of their effectiveness, which requires large randomized controlled trials. The purpose of this R21 application is to develop this evidence by demonstrating that deposit contracts with remote alcohol monitoring are feasible and provide evidence of effectiveness needed to design and justify future studies.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
80 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Piloting Deposit Contracts to Increase Accessibility of a Contingency Management Intervention to Reduce Problematic Drinking
Actual Study Start Date :
Jun 10, 2022
Anticipated Primary Completion Date :
May 31, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Monitoring Group Only

Individuals in the Monitoring only group will be required to put down a 200$ deposit but will earn it back non-contingently by attending the weekly study meetings. They will be monitored using the Transdermal Alcohol Monitoring device, but will not be required to meet any Alcohol reduction goals to earn their deposit back.

Other: Transdermal Alcohol Monitoring
Using a SCRAM-Cam device participants will be monitored for their alcohol use.

Experimental: Deposit Contract Group

Individuals in the Deposit COntract group will be required to put down a 200$ deposit but will earn it back, as well as a bonus, contingently for meeting alcohol reduction requirements. For this study, this is counted as having a Transdermal Alcohol COntent below equal to .02 g/dl. They will be monitored using the Transdermal Alcohol Monitoring device.

Behavioral: Deposit Contract
A deposit contract requires individuals to put down money that is earned back contingently upon meeting their goals.

Other: Transdermal Alcohol Monitoring
Using a SCRAM-Cam device participants will be monitored for their alcohol use.

Outcome Measures

Primary Outcome Measures

  1. Transdermal Alcohol Content [4 weeks continuously]

    Measurement produced while wearing Transdermal Alcohol Monitor

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • at least 21 years of age

  • report > 8 heavy drinking episodes during the last 28 days

  • want to reduce their alcohol use

  • are willing to wear a transdermal alcohol monitor

  • own a smartphone

  • are willing and able to deposit $200

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Of North Texas Denton Texas United States 76210

Sponsors and Collaborators

  • University of North Texas, Denton, TX
  • The University of Texas Health Science Center at San Antonio

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University of North Texas, Denton, TX
ClinicalTrials.gov Identifier:
NCT05837611
Other Study ID Numbers:
  • 22-22
First Posted:
May 1, 2023
Last Update Posted:
May 6, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 6, 2023